Llwytho...

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis

Alemtuzumab is a humanized monoclonal antibody directed against CD52 to deplete circulating T and B lymphocytes; lymphocyte depletion is followed by a distinctive pattern of T- and B-cell repopulation, changing the balance of the immune system. This review reports the efficacy and safety findings of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Mult Scler
Prif Awduron: Hartung, Hans-Peter, Aktas, Orhan, Boyko, Alexey N
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2015
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4361497/
https://ncbi.nlm.nih.gov/pubmed/25344374
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458514549398
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!